Gastric motility and its association with adiposity and metabolic health in a cohort of Sri Lankan office workers

Table 1 Categorization of participants according to age, adiposity, and metabolic markers, n (%)

Parameter	Category	Percentage distribution
		Total (n = 130)	Male (n = 54)	Females (n = 76)
Age (years)	20–30	35 (26.9)	9 (16.7)	26 (34.2)
	31-40	41 (31.5)	15 (27.8)	26 (34.2)
	41-50	54 (41.5)	30 (55.5)	24 (31.6)
Adiposity measures
BMI (kg/m2)	Underweight	6 (4.6)	3 (5.6)	3 (3.9)
	Normal	73 (56.2)	32 (59.3)	41 (53.9)
	Overweight	40 (30.8)	16 (29.6)	24 (31.6)
	Obesity - class 1	9 (6.9)	3 (5.6)	6 (7.9)
	Obesity - class 2	2 (1.5)	0 (0.0)	2 (2.6)
Body fat (%)	Normal	127 (97.7)	53 (98.1)	74 (97.4)
	Overweight/obese	3 (2.3)	1 (1.9)	2 (2.6)
Waist circumference (cm)	Normal	92 (70.8)	45 (83.3)	47 (61.8)
	Abdominal adiposity	38 (29.2)	9 (16.7)	29 (38.2)
Waist-to-hip ratio	Normal	77 (59.2)	41 (75.9)	36 (47.4)
	Health risk	53 (40.8)	13 (24.1)	40 (52.6)
Metabolic parameters
HbA1c (%)	Normal	104 (80.0)	41 (75.9)	63 (82.9)
	Pre-diabetes	19 (14.6)	9 (16.7)	10 (13.2)
	Diabetes	7 (5.4)	4 (7.4)	3 (3.9)
Total cholesterol (mg/dL)	Desirable	68 (52.3)	30 (55.6)	38 (50.0)
	Borderline high	48 (36.9)	18 (33.3)	30 (39.5)
	High	14 (10.8)	6 (11.1)	8 (10.5)
Triglycerides (mg/dL)	Normal	111 (85.4)	39 (72.2)	72 (94.7)
	Borderline high	11 (8.5)	8 (14.8)	3 (3.9)
	High	8 (6.2)	7 (13.0)	1 (1.3)
HDL (mg/dL)	Low	18 (13.8)	13 (24.1)	5 (6.6)
	Normal	82 (62.3)	38 (70.4)	43 (56.6)
	High	31 (23.8)	3 (5.6)	28 (36.8)
LDL (mg/dL)	Optimal	27 (20.8)	12 (22.2)	15 (19.7)
	Near-optimal	52 (40.0)	20 (37.0)	32 (42.1)
	High/very high	51 (39.2)	22 (40.8)	29 (38.2)
Liver enzymes
SGOT (U/L)	Normal	123 (94.6)	50 (92.6)	73 (96.1)
	Elevated	7 (5.4)	4 (7.4)	3 (3.9)
SGPT (U/L)	Normal	102 (78.5)	36 (66.7)	66 (86.8)
	Elevated	28 (21.5)	18 (33.3)	10 (13.2)

BMI: Body mass index; HbA1c: Glycated hemoglobin; HDL: High-density lipoproteins; LDL: Low-density lipoproteins; SGOT: Aspartate transaminase; SGPT: Alanine transaminase.